✦ LIBER ✦

Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study

✍ Scribed by Jeeyun Lee; Se Hoon Park; Heung-Moon Chang; Jun Suk Kim; Hye Jin Choi; Myung Ah Lee; Joung Soon Chang; Hei Cheul Jeung; Jung Hun Kang; Hyun Woo Lee; Dong Bok Shin; Hye Jin Kang; Jong-Mu Sun; Joon Oh Park; Young Suk Park; Won Ki Kang; Ho Yeong Lim

Book ID: 117785824
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 221 KB
Volume: 13
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(11)70301-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine and oxaliplatin with or with

Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial

✍ Malka, David; Cervera, Pascale; Foulon, Stéphanie; Trarbach, Tanja; de la Foucha 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 296 KB

Cetuximab, gemcitabine, and oxaliplatin

Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study

✍ Birgit Gruenberger; Johannes Schueller; Ute Heubrandtner; Fritz Wrba; Dietmar Ta 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 180 KB

Epirubicin, oxaliplatin, and capecitabin

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial

✍ Waddell, Tom; Chau, Ian; Cunningham, David; Gonzalez, David; Okines, Alicia Fran 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 396 KB

Prognostic and predictive value of metab

Prognostic and predictive value of metabolic tumor volume on18F-FDG PET/CT in advanced biliary tract cancer treated with gemcitabine/oxaliplatin with or without erlotinib

✍ Choi, Moon Ki; Choi, Joon Young; Lee, Jeeyun; Heo, Jin Seok; Choi, Seong Ho; Cho 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 334 KB

Gemcitabine alone or in combination with

Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 Study

✍ Valle, J W; Wasan, H; Johnson, P; Jones, E; Dixon, L; Swindell, R; Baka, S; Mara 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 204 KB

Gemcitabine and capecitabine with or wit

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

✍ Middleton, Gary; Silcocks, Paul; Cox, Trevor; Valle, Juan; Wadsley, Jonathan; Pr 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 385 KB